“…In addition, recent research has revealed potential alternatives such as behavioural modifications, immunoactive prophylactic agents, cranberry, D-mannose, and methenamine hippurate (Hiprex, Inova Pharmaceuticals, Chatswaood, NSW, Australia) amongst others [4]. There currently are no guidelines for the structured management of rUTIs in Australia incorporating appropriately prescribed antibiotics along with these other preventive strategies [7]. We conducted a retrospective cohort study with the aim of assessing how these patients are currently being managed within our department at Eastern Health (Australia), a large tertiary referral centre serving a population of >1 million.…”